Skip to main content
. 2021 Jan 6;22:4. doi: 10.1186/s12865-020-00395-4

Table 2.

Comparison of CD63-based BAT in patients diagnosed with or without asthma

CD63-based BAT Case, n(%) Asthma, n(%) Non-asthma, n(%) X2 p value
Positive 25 (65.8) 23 (85.2) 2 (18.2) 12.755 < 0.001*
Negative 13 (34.2) 4 (14.8) 9 (81.8)

* Continuity correction X2